Veldhuis Johannes D, Anderson Stacey M, Patrie James T, Bowers Cyril Y
Division of Endocrinology and Metabolism, Department of Internal Medicine, Mayo Medical and Graduate Schools of Medicine, General Clinical Research Center, Mayo Clinic, Rochester, Minnesota 55905, USA.
J Clin Endocrinol Metab. 2004 Jan;89(1):121-7. doi: 10.1210/jc.2003-031291.
We postulated that short-term estradiol replacement in postmenopausal women may act, in part, by facilitating endogenous GHRH release or action. A prediction of this hypothesis is that estradiol repletion should enhance postsomatostatin rebound GH secretion, which appears to be driven by hypothalamic outflow of GHRH. To this end, we administered placebo and estradiol to eight healthy estrogen-withdrawn postmenopausal volunteers in a prospectively randomized, patient-blinded, within-subject crossover design for a total of 36 d. Rebound release of GH was assessed between d 7 and 36 of intervention on separate randomly ordered mornings after continuous iv infusion of saline or somatostatin (9 micro g/kg.h for 3 h). Secretion was quantitated by frequent (10-min) blood sampling for 7 h, GH chemiluminescence assay, and deconvolution analysis. Compared with placebo, estradiol replacement: 1) stimulated spontaneous pulsatile GH secretion by 3.5-fold (95% confidence interval, 2.1- to 5.6-fold) (P < 0.001); and 2) amplified the mass of GH secreted in response to abrupt somatostatin withdrawal by 2.1-fold (95% confidence interval, 1.3- to 3.4-fold) (P = 0.003). Estrogenic augmentation of rebound-like GH secretion was specific, because the pharmacological effects of exogenous GHRH (1 micro g/kg) and GH-releasing peptide-2 (1 micro g/kg, a synthetic ghrelin analog) were not affected. In summary, short-term supplementation with estradiol in postmenopausal individuals doubles the mass of rebound-like GH secretion induced by abrupt somatostatin withdrawal without modifying stimulation by a pharmacological dose of GHRH or GH-releasing peptide-2. Accordingly, we hypothesize that estradiol stimulates pulsatile GH secretion, at least in part, by enhancing the release and/or action of hypothalamic GHRH.
我们推测,绝经后女性短期补充雌二醇可能部分通过促进内源性生长激素释放激素(GHRH)的释放或作用来发挥作用。该假设的一个预测是,补充雌二醇应能增强生长抑素抑制后的生长激素(GH)分泌反弹,这种反弹似乎是由下丘脑GHRH的释放驱动的。为此,我们采用前瞻性随机、患者盲法、自身交叉设计,对8名健康的绝经后雌激素缺乏志愿者给予安慰剂和雌二醇,为期共36天。在干预的第7天至第36天期间,在连续静脉输注生理盐水或生长抑素(9μg/kg·h,持续3小时)后的不同随机安排的早晨,评估GH的反弹释放。通过频繁(每10分钟)采血7小时、GH化学发光测定和去卷积分析来定量分泌情况。与安慰剂相比,补充雌二醇:1)使自发性脉冲式GH分泌增加3.5倍(95%置信区间为2.1至5.6倍)(P<0.001);2)使因突然停用生长抑素而分泌的GH量增加2.1倍(95%置信区间为1.3至3.4倍)(P = 0.003)。雌激素对类似反弹的GH分泌的增强作用具有特异性,因为外源性GHRH(1μg/kg)和生长激素释放肽-2(1μg/kg,一种合成的胃饥饿素类似物)的药理作用未受影响。总之,绝经后个体短期补充雌二醇可使因突然停用生长抑素而诱导的类似反弹的GH分泌量增加一倍,而不改变药理剂量的GHRH或生长激素释放肽-2的刺激作用。因此,我们假设雌二醇至少部分通过增强下丘脑GHRH的释放和/或作用来刺激脉冲式GH分泌。